Capricor Therapeutics Stock Performance
as on September 18, 2026 at 1:08 am IST
Day's Low
Day's High
$8.82$9.22
2.43%
Downside
1.99%
Upside
52 Week's Low
52 Week's High
$2.96$40.3767.26%
Downside
346.57%
Upside
Capricor Therapeutics share price movements today
- Previous Close
- $8.56
- Open
- $8.92
- Volume
- 620.9K
- Market Cap
- $497.7M
- Day's Low - High
- $8.82 - $9.22
- 52 Week Low - High
- $2.96 - $40.37
Capricor Therapeutics Historical Returns
- 1 Month Return
- + 14.9 %
- 3 Month Return
- -69.37 %
- 1 Year Return
- + 40.79 %
- 3 Year Return
- + 36.74 %
- 5 Year Return
- + 70.18 %
Capricor Therapeutics Stock Fundamentals & Key Indicators
Check Capricor Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$497.7M
EPS (TTM)
-2.45
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.49
Industry PE ratio
-6.71
PEG Ratio
0.09130369321249543
EBITDA
1.2B
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-56.60%
Capricor Therapeutics Stock Valuation
Track how Capricor Therapeutics P/E has moved over time to understand its valuation trends.
Capricor Therapeutics in the last 5 years
Lowest (-12.77x)
December 31, 2025
Today (-12.77x)
December 31, 2025
Industry (-6.71x)
December 31, 2025
Highest (-3.27x)
December 31, 2022
Today’s Price to Earnings Ratio: -12.77x
Capricor Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Capricor Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $497.7M | 70.18% | -3.49 | 0.00% | 0.00% | |
| BUY | $43.9B | 527.35% | NA | 0.00% | 0.00% | |
| BUY | $130.4B | 172.58% | 29.71 | 86.04% | 0.00% | |
| BUY | $57.4B | -66.14% | -18.02 | -12.57% | 0.00% | |
| BUY | $81.7B | 18.83% | 18.48 | 84.86% | 0.48% |
Stock Returns calculator for Capricor Therapeutics Stock including INR - Dollar returns
The Capricor Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Capricor Therapeutics investment value today
Current value as on today
₹1,62,298
Returns
₹62,298
(+62.3%)
Returns from Capricor Therapeutics Stock
₹48,684 (+48.68%)
Dollar Impact
₹13,614 (+13.61%)
Analyst Recommendation on Capricor Therapeutics Stock
Based on 10 analysts
40.00%
Buy
60.00%
Hold
0.00%
Sell
Based on 10 analysts, 60% of analysts recommend a 'BUY' rating for Capricor Therapeutics. Average target price of $27
Capricor Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Capricor Therapeutics.
What analysts predicted
66.52%UPSIDE
Target Price
$27
Current Price
$9.04
Analyzed by
10 Analysts
Target
$27.00
Capricor Therapeutics target price $27, a slight upside of 66.52% compared to current price of $9.04. According to 10 analysts rating.
Indian Investors' Interest in Capricor Therapeutics Stock
Investment in Capricor Therapeutics Shares on INDmoney has grown by 6.25% in the last 30 days, indicating increased investment activity.
Time period: to
Change:6.25% versus previous 30 day period
Search interest for Capricor Therapeutics Stock has increased by 68% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:68% versus previous 30 day period
Capricor Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Capricor Therapeutics Annual Profit & Loss
All numbers in Millions USD
Capricor Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Capricor Therapeutics Annual Cash Flow
All numbers in Millions USD
Capricor Therapeutics News & Key Events
Today's Timeline - 21 January
Wed, 04:41 PM
-Capricor updates on Deramiocel BLA; FDA requests full HOPE-3 study report, no new trials needed.
Insights on Capricor Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, CAPR stock has moved up by 14.9%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.26M → 11.13M (in $), with an average increase of 79.7% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CAPR has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 482.5% return, outperforming this stock by 441.7%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 4 quarters, -24.57M → -40.73M (in $), with an average decrease of 18.4% per quarter
About Capricor Therapeutics
| Organisation | Capricor Therapeutics |
| Headquarters | 10865 Road to the Cure, San Diego, CA, United States, 92121 |
| Industry | Biotechnology |
| CEO | Dr. Linda Marbán Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Capricor Therapeutics
Name | Title |
|---|---|
Dr. Frank Isaac Litvack FACC, M.D. | Executive Chairman of the Board |
Dr. Linda Marbán Ph.D. | Co-Founder, President, CEO & Director |
Mr. Anthony J. Bergmann M.B.A. | CFO & Corporate Treasurer |
Ms. Karen G. Krasney Esq., J.D. | Executive VP, General Counsel & Secretary |
Mr. Mark Awadalla | Chief Development Officer |
Dr. Micheal Binks M.D. | Chief Medical Officer |
Mr. Michael Maurer | Chief Commercial Officer |
Nathaniel Hogan Ph.D. | Director of Biostatistics of Capricor Therapeutics |
Dr. Kristi A. H. Elliott Ph.D. | Chief Operating & Science Officer |
Mr. Minghao Sun Ph.D. | Senior Vice President of Quality Control, Research & Product Development |
FAQs
What is Capricor Therapeutics share price today?
Capricor Therapeutics share price today is $9.04 as on . Capricor Therapeutics share today touched a day high of $9.22 and a low of $8.82.
What is the 52 week high and 52 week low for Capricor Therapeutics share?
Capricor Therapeutics share touched a 52 week high of $40.37 on and a 52 week low of $2.96 on . Capricor Therapeutics stock price today i.e. is trending at $9.04,which is 77.61% down from its 52 week high and 205.41% up from its 52 week low.
What is Capricor Therapeutics's market capitalisation today?
Capricor Therapeutics market capitalisation is $0.00T as on .
How to invest in Capricor Therapeutics Stock (CAPR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Capricor Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Capricor Therapeutics Shares that will get you 0.1659 shares as per Capricor Therapeutics share price of $9.04 per share as on September 17, 2026 at 7:38 pm IST.
What is the minimum amount required to buy Capricor Therapeutics Stock (CAPR) from India?
Indian investors can start investing in Capricor Therapeutics (CAPR) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in Capricor Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Capricor Therapeutics share’s latest price of $9.04 as on September 17, 2026 at 7:38 pm IST, you will get 1.1062 shares of Capricor Therapeutics. Learn more about
fractional shares .
What are the returns that Capricor Therapeutics has given to Indian investors in the last 5 years?
Capricor Therapeutics stock has given 70.18% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?